Keurig Dr Pepper Inc. (NASDAQ:KDP) Given Average Rating of “Moderate Buy” by Analysts

Keurig Dr Pepper Inc. (NASDAQ:KDP) has earned an average recommendation of “Moderate Buy” from the fourteen analysts that are presently covering the stock, Marketbeat reports. Six equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The average 1-year target price among analysts that have issued ratings on the stock in the last year is $36.50.

Several research analysts have commented on the stock. UBS Group upped their price objective on shares of Keurig Dr Pepper from $39.00 to $40.00 and gave the stock a “buy” rating in a report on Monday, June 10th. TD Cowen increased their price target on shares of Keurig Dr Pepper from $32.00 to $35.00 and gave the stock a “hold” rating in a research note on Friday, April 26th. Wells Fargo & Company raised their price objective on shares of Keurig Dr Pepper from $39.00 to $41.00 and gave the stock an “overweight” rating in a report on Wednesday, June 5th. Barclays reduced their target price on Keurig Dr Pepper from $38.00 to $37.00 and set an “overweight” rating on the stock in a report on Friday, July 19th. Finally, Royal Bank of Canada restated an “outperform” rating and issued a $41.00 target price on shares of Keurig Dr Pepper in a research note on Friday, July 26th.

Keurig Dr Pepper Stock Performance

Keurig Dr Pepper stock opened at $35.62 on Tuesday. The company has a current ratio of 0.51, a quick ratio of 0.34 and a debt-to-equity ratio of 0.50. The firm has a market cap of $48.29 billion, a P/E ratio of 22.98, a P/E/G ratio of 2.60 and a beta of 0.62. Keurig Dr Pepper has a 1-year low of $27.66 and a 1-year high of $35.64. The firm has a 50-day moving average of $33.79 and a 200-day moving average of $32.45.

Keurig Dr Pepper (NASDAQ:KDP) last released its quarterly earnings data on Thursday, July 25th. The company reported $0.45 earnings per share for the quarter, hitting the consensus estimate of $0.45. The business had revenue of $3.92 billion during the quarter, compared to analysts’ expectations of $3.91 billion. Keurig Dr Pepper had a return on equity of 10.32% and a net margin of 14.47%. The business’s revenue was up 3.5% on a year-over-year basis. During the same quarter last year, the business posted $0.42 EPS. Sell-side analysts expect that Keurig Dr Pepper will post 1.92 EPS for the current year.

Insider Transactions at Keurig Dr Pepper

In other Keurig Dr Pepper news, insider Matthew Andrew Archambault sold 8,000 shares of the stock in a transaction on Thursday, May 23rd. The stock was sold at an average price of $34.19, for a total transaction of $273,520.00. Following the sale, the insider now directly owns 12,565 shares in the company, valued at approximately $429,597.35. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 1.00% of the company’s stock.

Institutional Investors Weigh In On Keurig Dr Pepper

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Capital World Investors boosted its stake in shares of Keurig Dr Pepper by 14.6% in the 4th quarter. Capital World Investors now owns 108,032,566 shares of the company’s stock worth $3,599,652,000 after buying an additional 13,738,345 shares during the last quarter. Vanguard Group Inc. grew its stake in shares of Keurig Dr Pepper by 9.4% during the 1st quarter. Vanguard Group Inc. now owns 90,840,391 shares of the company’s stock valued at $2,786,075,000 after purchasing an additional 7,825,418 shares during the period. Capital International Investors increased its position in shares of Keurig Dr Pepper by 1.3% during the 4th quarter. Capital International Investors now owns 56,060,464 shares of the company’s stock valued at $1,867,937,000 after purchasing an additional 730,112 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its stake in shares of Keurig Dr Pepper by 107.6% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 23,654,577 shares of the company’s stock worth $725,487,000 after purchasing an additional 12,259,471 shares during the period. Finally, Barrow Hanley Mewhinney & Strauss LLC boosted its holdings in shares of Keurig Dr Pepper by 2.4% in the second quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 13,342,765 shares of the company’s stock worth $445,648,000 after buying an additional 317,837 shares during the last quarter. Hedge funds and other institutional investors own 85.23% of the company’s stock.

Keurig Dr Pepper Company Profile

Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.